The much-talked-about Retatrutide 20mg injection , a novel dual GIP and GLP-1 target , is currently being assessed by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. General access https://buyretatrutideweightloss.co.uk/product/alluvi-tirzepatide-40mg/